1245.19.20031 Boehringer Ingelheim Investigational Site

St. John's, Newfoundland and Labrador

0 studies enrolling now · 1 studies all time

What they study most

Diabetes Mellitus, Type 2

Studies at this site

• Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin — Completed